 |
| 首页 > 美迪医讯 > Research Report on amoxicillin & clavulanic acid |
Research Report on amoxicillin & clavulanic acid 【 2008-08-12 发布 】 美迪医讯
Research Report on amoxicillin & clavulanic acidPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$3,200
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Foreword
1 Sales analysis of finished drug in sample hospital
1.1 Growth rate in the past 5 years(Sales value etc.)
1.2 Sales analysis of finished drug for injection
1.3 Sales analysis of finished drug for oral
1.4 Demanded volume of bulk drug for key enterprise
1.5 Market forecast about domestic finished drug market
2 Export analysis of bulk drug
2.1 Change of import volume in the past few years
2.2 Domestic demand for bulk drug
Market Research Report on non-steroid antiinflammatory drugsPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$2,400
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Foreword
1 Application market of non-steroid antiinflammatory drugs
1.1 Epidemiology of rheumatoid arthritis
1.2 Use Rate of non-steroid antiinflammatory drugs
1.3 Categories of non-steroid antiinflammatory drugs
1.4 Breeds included in Catalogue of Drugs for Basic National Medical Insurance
1.5 Categories of non-prescription drug
2 Categories and action mechanism
2.1 Categories classified according to chemical structure
2.2 Categories classified according to action mechanism
2.3 Category of immunosuppressant
3 Market analysis of the past few years
3.1 Change trend(including sales value, share of different products etc.)
3.2 Analysis of hospital sales last year
3.3 Analysis of pharmacy sales last year
3.4 Indicative retail price of key products
4 Sales analysis of different categories
(including sales value, enterpsise share etc.)
4.1 acetic acid class
Diclofenac
4.2 propanoic acid class
Ibuprofen
4.3 COX-2 inhibitor
Rofecoxib
Celecoxib
4.4 Nonacid class
Nabumetone
Nimesulide
4.5 immunosuppressant
auranofin tablets
Leflunomide
4.6 Compound
4.7 salicylates
4.8 Oxiacams
Meloxicam
Lornoxicam
Piroxicam
4.9 Others
aminoglucose
Ossotide
5 Key enterprises
Beijing Novartis Pharma Ltd.
Italy Rotta Research Laboratorium SpA
Tianjin Smith Kline & French laboratories Ltd
UPJOHN PHARMACY CO.,LTD
Suzhou Changzheng Cinkate Pharmacy Company
Johnson & Johnson China (Shanghai) Ltd.
Hangzhou MSD Pharmaceutical Co. Ltd
Heilongjiang Jiangshi Pharmaceutical Company Limited
Boehringer Ingelheim microParts GmbH
本文关键字:
收藏本文到:
          .text:''):(d.getSelection?d.getSelection():'');void(keyit=window.open('http://my.poco.cn/fav/storeIt.php?t='+escape(d.title)+'&u='+escape(d.location.href)+'&c='+escape(t)+'&img=http://www.h-strong.com/blog/logo.gif','keyit','scrollbars=no,width=475,height=575,status=no,resizable=yes'));keyit.focus(); "添加到POCO网摘"){kind=logo}  《美迪医讯》欢迎您参与新闻投稿，业务咨询： 美迪医疗网业务咨询《上海医疗器械批发》产品推荐
|
| 合作支持：中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会 |
| 刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图 |
| 把美迪网放进收藏夹 把美迪医疗网介绍给我的朋友 给美迪医疗网留言
美迪医疗网广告业务联系：021-51601230 产品咨询业务联系：021-51601230 传真：021-56532303 
美迪医疗网业务咨询
互联网药品信息服务许可证：(沪)-经营性-2009-0003 中华人民共和国电信与信息服务业务经营许可证：(沪)B2-20090029  沪ICP备14001091号-8  公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号 营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081 |
